Modakafusp alfa shows intratumoral immune pharmacodynamics (PD) in a subset of patients (pts) in a phase 1b study in advanced/metastatic solid tumors

被引：0
|
作者：
Saggu, Gurpanna
Markman, Janet L.
Lee, Min Young
Dunbar, Faith
Joshi, Adarsh
Wang, Shining
Collins, Sabrina
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT065
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
    Dirix, Luc Y.
    Takacs, Istvan
    Jerusalem, Guy
    Nikolinakos, Petros
    Arkenau, Hendrik-Tobias
    Forero-Torres, Andres
    Boccia, Ralph
    Lippman, Marc E.
    Somer, Robert
    Smakal, Martin
    Emens, Leisha A.
    Hrinczenko, Borys
    Edenfield, William
    Gurtler, Jayne
    von Heydebreck, Anja
    Grote, Hans Juergen
    Chin, Kevin
    Hamilton, Erika P.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (03) : 671 - 686
  • [22] Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
    Luc Y. Dirix
    Istvan Takacs
    Guy Jerusalem
    Petros Nikolinakos
    Hendrik-Tobias Arkenau
    Andres Forero-Torres
    Ralph Boccia
    Marc E. Lippman
    Robert Somer
    Martin Smakal
    Leisha A. Emens
    Borys Hrinczenko
    William Edenfield
    Jayne Gurtler
    Anja von Heydebreck
    Hans Juergen Grote
    Kevin Chin
    Erika P. Hamilton
    Breast Cancer Research and Treatment, 2018, 167 : 671 - 686
  • [23] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.
    Paluri, Ravi Kumar
    Li, Peng
    Jones, Benjamin Scott
    Madan, Ankit
    Jerome, Mary
    Miley, Debi
    Keef, Jennifer
    Robert, Francisco
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Interim results of a phase 1b/2 study of ADG126 (a masked anti-CTLA-4 SAFEbody®) monotherapy and in combination with toripalimab (an anti-PD-1 antibody) in patients (pts) with advanced/metastatic solid tumors
    Ariyapperuma, Mihitha
    Park, John J.
    Khattak, Adnan
    Richardson, Gary
    Hamid, Anis
    Morris, Michelle
    Tolcher, Anthony W.
    Goh, Boon Cher
    Lam, Justina
    Chmielowski, Bartosz
    She, Kristine
    Zhang, Yanyan
    Li, Ai
    Zheng, Songmao
    Liu, Guizhong
    Zhu, Lvyu
    Wang, Hongyan
    Cui, Xiaoxing
    Luo, Peter
    Zha, Jiping
    CANCER RESEARCH, 2023, 83 (08)
  • [25] A phase 1b, open-label, dose escalation and expansion study of demcizumab plus pembrolizumab in patients with locally advanced or metastatic solid tumors
    Johnson, Melissa
    Rasco, Drew
    Schneider, Brian
    Shu, Catherine
    Jotte, Robert
    Parmer, Hema
    Stagg, Robert
    Lopez, Juanita
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [26] Pharmacokinetics/pharmacodynamics (PK/PD) of ivosidenib in patients with IDH1-mutant advanced solid tumors from a phase 1 study.
    Fan, Bin
    Mellinghoff, Ingo K.
    Wen, Patrick Y.
    Pandya, Shuchi Sumant
    Jiang, Liewen
    Liu, Guowen
    Nimkar, Tara
    Yang, Hua
    Dai, David
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Phase 1 study of sorafenib and eribulin in patients with advanced, metastatic or refractory solid tumors
    Marme, F.
    Gomez-Roca, C.
    Graudenz, K.
    Huang, F.
    Lettieri, J.
    Pena, C.
    Trnkova, Z.
    Eucker, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] A phase 1/1b study of RXDX-105, an oral RET and BRAF inhibitor, in patients with advanced solid tumors
    Drilon, A.
    Marwan, F.
    Fu, S.
    Patel, M. R.
    Olszanski, A. J.
    Lockhart, A. C.
    Liu, S. V.
    Bazhenova, L.
    Seery, T.
    Nikolinakos, P.
    Patel, R.
    Oliver, J. W.
    Multani, P. S.
    Wang, D.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S143 - S143
  • [29] A Phase 1B Study of the Anti-PD-1 Monoclonal Antibody, Tislelizumab, in Combination with the Parp Inhibitor, Pamiparib, in Advanced Solid Tumors
    Friedlander, M.
    Meniawy, T.
    Markman, B.
    Mileshkin, L. R.
    Harnett, P.
    Millward, M.
    Lundy, J.
    Freimund, A. E.
    Norris, C.
    Wu, J.
    Paton, V.
    Wang, L.
    Gao, B.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 58 - 59
  • [30] Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors: ARTISTRY-1
    Vaishampayan, Ulka N.
    Tomczak, Piotr
    Muzaffar, Jameel
    Winer, Ira Seth
    Rosen, Seth David
    Hoimes, Christopher J.
    Chauhan, Aman
    Spreafico, Anna
    Lewis, Karl D.
    Bruno, Debora S.
    Dumas, Olivier
    McDermott, David F.
    Strauss, James Fredric
    Chu, Quincy S.
    Gilbert, Lucy
    Chaudhry, Arvind
    Graham, Julie R.
    Boni, Valentina
    Ernstoff, Marc S.
    Velcheti, Vamsidhar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345